Alzheimer's Disease

Doug Whitney, center, eats breakfast with his family in Manson, Wash., on Nov. 5, 2022. Whitney inherited the same gene mutation that gave Alzheimer’s disease to his mother, brother and generations of other relatives by the unusually young age of 50. Doug is a healthy 73, his mind still sharp. Somehow, he escaped his genetic fate. (AP Photo/Shelby Lum)

Science seeking Alzheimer’s clues from few who escape genetic fate

Researchers could uncover and mimic whatever protects those who escaped fate of their families

 

First Link® Dementia Helpline can provide you with the support and answeres you need.

Stand up against dementia stigma this Alzheimer’s Awareness Month

Jana Schulz of Cranbrook, B.C. – a registered social worker, working as…

  • Jan 9, 2023

 

Chilliwack’s Taylor Ogston, seen here with wife Karen Stewart, was diagnosed three and a half years ago with mild cognitive impairment. Through the Alzheimer Society of B.C., he is sharing his story of living with dementia. (Submitted)

‘I’m embracing it’: Fraser Valley man shares story during Alzheimer’s Awareness Month

Taylor Ogston is 1 of 5 people living with dementia featured on Alzheimer Society of B.C. website

 

FILE — The Biogen Inc., headquarters is shown March 11, 2020, in Cambridge, Mass. Shares of Biogen and other drugmakers researching Alzheimer’s disease soared early Wednesday, Sept. 28, 2022, after Japan’s Eisai Co. said its potential treatment appeared to slow the fatal disease’s progress in a late-stage study. Eisai announced results late Tuesday from a global study of nearly 1,800 people with early-stage Alzheimer’s (AP Photo/Steven Senne, File)

VIDEO: Alzheimer’s drug shows promise in early results of study

Patient decline reduced by 27% in initial study

FILE — The Biogen Inc., headquarters is shown March 11, 2020, in Cambridge, Mass. Shares of Biogen and other drugmakers researching Alzheimer’s disease soared early Wednesday, Sept. 28, 2022, after Japan’s Eisai Co. said its potential treatment appeared to slow the fatal disease’s progress in a late-stage study. Eisai announced results late Tuesday from a global study of nearly 1,800 people with early-stage Alzheimer’s (AP Photo/Steven Senne, File)
A new study estimates that 6.3 million Canadians will be diagnosed and living with dementia in the next 30 years (Photo: Alzheimer Society)

Canada could see tripling of people living with dementia in next 30 years: Landmark study

The Alzheimer Society of Canada released a study that predicts triple the number of diagnoses

A new study estimates that 6.3 million Canadians will be diagnosed and living with dementia in the next 30 years (Photo: Alzheimer Society)
Climbers participate in the Climb for Alzheimer’s event in the past. (Alzheimers Society photo)

Abbotsford residents invited to Climb for Alzheimer’s

Alzheimer Society of B.C. climb raises funds to support people living with dementia

Climbers participate in the Climb for Alzheimer’s event in the past. (Alzheimers Society photo)
In this 2019 photo provided by Biogen, a researcher works on the development of the medication aducanumab in Cambridge, Mass. On Monday, June 7, 2021, the Food and Drug Administration approved aducanumab, the first new drug for Alzheimer’s disease in nearly 20 years, disregarding warnings from independent advisers that the much-debated treatment hasn’t been shown to help slow the brain-destroying disease. (Biogen via AP)

U.S. approves much-debated Alzheimer’s drug aducanumab panned by experts

Drug from Biogen deemed “reasonably likely” to benefit Alzheimer’s patients

In this 2019 photo provided by Biogen, a researcher works on the development of the medication aducanumab in Cambridge, Mass. On Monday, June 7, 2021, the Food and Drug Administration approved aducanumab, the first new drug for Alzheimer’s disease in nearly 20 years, disregarding warnings from independent advisers that the much-debated treatment hasn’t been shown to help slow the brain-destroying disease. (Biogen via AP)
Katie Hogan (right, with hat and sunglasses) was diagnosed with early-onset Alzheimer’s disease in January. The 43-year-old Chilliwack woman is seen here taking part in the Walk for Alzheimer’s with family and friends on the Vedder Rotary Trail on Saturday, May 29, 2021. (Jenna Hauck/ Chilliwack Progress)

Alzheimer’s can strike at young age, says 43-year-old Chilliwack woman with disease

Katie Hogan raising awareness for early-onset Alzheimer’s, brings in more than $6,000 on walk

Katie Hogan (right, with hat and sunglasses) was diagnosed with early-onset Alzheimer’s disease in January. The 43-year-old Chilliwack woman is seen here taking part in the Walk for Alzheimer’s with family and friends on the Vedder Rotary Trail on Saturday, May 29, 2021. (Jenna Hauck/ Chilliwack Progress)
Ron Restrick lives with mild cognitive impairment, but has worked to stay active and engaged in his community.

Abbotsford residents invited to Alzheimer Society webinar

Session on Wednesday, Jan. 27 looks at dementia and long-term care

Ron Restrick lives with mild cognitive impairment, but has worked to stay active and engaged in his community.
Talia Yorish, 10, is encouraging Lower Mainland residents to join her in her fundraising efforts for the Alzheimer Society of B.C. She is climbing the Grouse Grind in memory of her grandmother, Mariam, who battled Lewy body dementia before passing away last April. (Contributed photo)

Climb for Alzheimer’s encourages Lower Mainland residents to walk or hike for a cure

North Vancouver 10-year-old taking part in Grouse Grind climb in honour of grandmother

  • Sep 9, 2020
Talia Yorish, 10, is encouraging Lower Mainland residents to join her in her fundraising efforts for the Alzheimer Society of B.C. She is climbing the Grouse Grind in memory of her grandmother, Mariam, who battled Lewy body dementia before passing away last April. (Contributed photo)
Pop-up banner image